Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Addendum: Liquid biopsy and multi-analyte testing guided treatment of HER2 positive periampullary adenocarcinoma with durable complete response after trastuzumab based therapy.
Nagarkar R, Patil D, Limaye S, Devhare P, Ghaisas A, Srivastava N, Apurwa S, Patil S, John J, Raazi Z, Shreenivas A, Sambath J, Srinivasan A, Kumar P, Akolkar D, Datar R. Nagarkar R, et al. Oncotarget. 2022 Nov 2;13:1215. doi: 10.18632/oncotarget.28296. Oncotarget. 2022. PMID: 36342460 Free PMC article. No abstract available.
Liquid biopsy and multi-analyte testing guided treatment of HER2 positive periampullary adenocarcinoma with durable complete response after trastuzumab based therapy.
Nagarkar R, Patil D, Limaye S, Devhare P, Ghaisas A, Srivastava N, Apurwa S, Patil S, John J, Raazi Z, Shreenivas A, Sambath J, Srinivasan A, Kumar P, Akolkar D, Datar R. Nagarkar R, et al. Oncotarget. 2020 Nov 10;11(45):4195-4200. doi: 10.18632/oncotarget.27793. eCollection 2020 Nov 10. Oncotarget. 2020. PMID: 33227091 Free PMC article.
Comparison of the Efficacy, Safety, Pharmacokinetic and Immunogenicity of UJVIRA (ZRC-3256, Trastuzumab Emtansine) With the Kadcyla (Trastuzumab Emtansine) in the Treatment of HER2-Positive Metastatic Breast Cancer: A Randomized, Open-Label, Multicenter Study in India.
Chiradoni Thungappa S, Maksud T, Raut N, Nagarkar R, Batra U, Kumar S, Parmar D; Study Investigator Group. Chiradoni Thungappa S, et al. Among authors: nagarkar r. Clin Breast Cancer. 2022 Jun;22(4):300-307. doi: 10.1016/j.clbc.2021.11.006. Epub 2021 Nov 27. Clin Breast Cancer. 2022. PMID: 34955432 Clinical Trial.
A case report of high-grade astroblastoma in a young adult.
Bhalerao S, Nagarkar R, Adhav A. Bhalerao S, et al. Among authors: nagarkar r. CNS Oncol. 2019 Mar;8(1):CNS29. doi: 10.2217/cns-2018-0012. Epub 2019 Feb 28. CNS Oncol. 2019. PMID: 30813777 Free PMC article.
Oral malignancy and its fickle blow off: A retrospective study.
Nagarkar R, Wagh A, Kokane G, Roy S, Palawe V, Kulkarni N, Pawar S. Nagarkar R, et al. J Cancer Res Ther. 2019 Jul-Sep;15(3):604-607. doi: 10.4103/jcrt.JCRT_188_18. J Cancer Res Ther. 2019. PMID: 31169227 Free article.
64 results